Inflammation and Oxidative Damage in Fatty Acids Oxidation Disorders.
- 1Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande, Brazil.
- 2Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande, Brazil.
Abstract
Deficiencies in enzymes and transporters involved in mitochondrial fatty acid beta oxidation results in the accumulation of fatty acids, a condition known as fatty acid oxidation disorders (FAODs). Therefore, the present study aimed to evaluate the oxidative and inflammatory profiles of treated patients with FAODs, comparing those receiving dietary treatment and l-carnitine supplementation with one untreated FAOD patient, to provide new insights into the pathophysiology and treatment of this group of diseases. Samples from 12 treated FAOD patients, 18 age-matched controls, and one untreated patient at diagnosis were included in the study. Levels of 8-isoprostanes, DNA and RNA oxidative damage, nitrite and nitrate, cathepsin D and cytokines were measured in urine and/or plasma samples, depending on the analyte, of FAODs patients under treatment (mean: 3.0 ± 2.9 years) and of an untreated patient with increased levels of several organic acids, who was included as an illustrative case and not considered in the statistical analyses. Levels of 8-isoprostanes, nitrite and nitrate, DNA damage, and interleukins 1β, 8, and 10 did not differ significantly between treated patients and control group, whereas IL-6 levels were increased in FAODs patients. These findings indicate that treated FAOD patients presented oxidative and inflammatory biomarker levels similar to those of controls for most analytes, while IL-6 remained elevated. The results suggest a potential beneficial effect of current treatment on oxidative and inflammatory profiles.
Related
- Txnip/PDK4-Mediated Hyperdependence on Fatty-Acid Oxidation Amplifies Susceptibility of Diabetic Myocardium to Ischemia-Reperfusion Damage.
- Changes of thioredoxin, oxidative stress markers, inflammation and muscle/renal damage following intensive endurance exercise
- Prohibitive Effects of ω-3 on Pancreatic Damage in an Experimental Diabetes Model: Blood Glucose, Insulin, Lipid Profiles, Oxidative Stress, Inflammation, Pancreatic Tissue Morphology, and Apoptotic Pathways.
- Pterostilbene attenuates VCD-induced ovarian damage through modulation of oxidative stress, inflammation, apoptosis, and SIRT1/FOXO3a gene expression
- Constitutive PI3K-AKT activation promotes steatohepatitis through de novo lipogenesis despite enhanced mitochondrial β-oxidation, essential fatty acid depletion and reduced lipid peroxidation
BibTeX
@article{altenhofen2026inflammation,
title = {{Inflammation and Oxidative Damage in Fatty Acids Oxidation Disorders.}},
author = {Stefani Altenhofen and Luísa Tedesco and Franciele Fátima Lopes and Marina Acosta and Ângela Sitta and Daniella de Moura Coelho and Bianca Gomes Dos Reis and Luiza Wailer and Debora Tonelotto and Ana Kalise Bottcher and Moacir Wajner and Carmen Regla Vargas},
journal = {Cell biochemistry and function},
year = {2026},
month = nov,
doi = {10.1002/cbf.70328},
url = {https://europepmc.org/article/MED/42974937},
note = {CC BY},
}
RIS
TY - JOUR
TI - Inflammation and Oxidative Damage in Fatty Acids Oxidation Disorders.
AU - Stefani Altenhofen
AU - Luísa Tedesco
AU - Franciele Fátima Lopes
AU - Marina Acosta
AU - Ângela Sitta
AU - Daniella de Moura Coelho
AU - Bianca Gomes Dos Reis
AU - Luiza Wailer
AU - Debora Tonelotto
AU - Ana Kalise Bottcher
AU - Moacir Wajner
AU - Carmen Regla Vargas
PY - 2026
DA - 2026/11/01
JO - Cell biochemistry and function
DO - 10.1002/cbf.70328
UR - https://europepmc.org/article/MED/42974937
AB - Deficiencies in enzymes and transporters involved in mitochondrial fatty acid beta oxidation results in the accumulation of fatty acids, a condition known as fatty acid oxidation disorders (FAODs). Therefore, the present study aimed to evaluate the oxidative and inflammatory profiles of treated patients with FAODs, comparing those receiving dietary treatment and l-carnitine supplementation with one untreated FAOD patient, to provide new insights into the pathophysiology and treatment of this group of diseases. Samples from 12 treated FAOD patients, 18 age-matched controls, and one untreated patient at diagnosis were included in the study. Levels of 8-isoprostanes, DNA and RNA oxidative damage, nitrite and nitrate, cathepsin D and cytokines were measured in urine and/or plasma samples, depending on the analyte, of FAODs patients under treatment (mean: 3.0 ± 2.9 years) and of an untreated patient with increased levels of several organic acids, who was included as an illustrative case and not considered in the statistical analyses. Levels of 8-isoprostanes, nitrite and nitrate, DNA damage, and interleukins 1β, 8, and 10 did not differ significantly between treated patients and control group, whereas IL-6 levels were increased in FAODs patients. These findings indicate that treated FAOD patients presented oxidative and inflammatory biomarker levels similar to those of controls for most analytes, while IL-6 remained elevated. The results suggest a potential beneficial effect of current treatment on oxidative and inflammatory profiles.
SN - 0263-6484
SN - 1099-0844
ER -